| Literature DB >> 27008863 |
Daniel R Dries1, Yi Zhu2, Mieu M Brooks2, Diego A Forero3, Megumi Adachi4, Basar Cenik2, James M West2, Yu-Hong Han2, Cong Yu2, Jennifer Arbella5, Annelie Nordin6, Rolf Adolfsson6, Jurgen Del-Favero7, Q Richard Lu8, Patrick Callaerts9, Shari G Birnbaum4, Gang Yu10.
Abstract
The biological underpinnings and the pathological lesions of psychiatric disorders are centuries-old questions that have yet to be understood. Recent studies suggest that schizophrenia and related disorders likely have their origins in perturbed neurodevelopment and can result from a large number of common genetic variants or multiple, individually rare genetic alterations. It is thus conceivable that key neurodevelopmental pathways underline the various genetic changes and the still unknown pathological lesions in schizophrenia. Here, we report that mice defective of the nicastrin subunit of γ-secretase in oligodendrocytes have hypomyelination in the central nervous system. These mice have altered dopamine signaling and display profound abnormal phenotypes reminiscent of schizophrenia. In addition, we identify an association of the nicastrin gene with a human schizophrenia cohort. These observations implicate γ-secretase and its mediated neurodevelopmental pathways in schizophrenia and provide support for the "myelination hypothesis" of the disease. Moreover, by showing that schizophrenia and obsessive-compulsive symptoms could be modeled in animals wherein a single genetic factor is altered, our work provides a biological basis that schizophrenia with obsessive-compulsive disorder is a distinct subtype of schizophrenia.Entities:
Keywords: Alzheimer disease; gamma-secretase; gene knockout; hypomyelination; myelin; nicastrin; obsessive-compulsive disorder; oligodendrocyte; schizophrenia; white matter
Mesh:
Substances:
Year: 2016 PMID: 27008863 PMCID: PMC4882434 DOI: 10.1074/jbc.M116.715078
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157